Differential Expression of Platelet Activation Markers CD62P and CD63 Following Stimulation with PAF, Arachidonic Acid and Collagen

References

• Gresele P. The platelet in asthma. The Platelet in Health and Disease, C P. Page. Blackwell Scientific Publications, Oxford 1991; 132–157
   Google Scholar
• Weksler B B. Platelets in Inflammation. Basic Principles and Clinical Correlates2nd ed, J. I. Gallin, I. M. Goldstein. Raven Press Ltd, New York 1992; 727–746, eds.
   Google Scholar
• Tschoepe D, Roesen P, Esser J, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433–438
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar
• Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1–12
   PubMed Web of Science ®Google Scholar
• Averill F J., Hubbard W C., Proud D, Gleich G J. Platelet activation in the lung after antigen challenge in a model of allergic asthma. 1992; 145: 571–576, Am Rev Respir Dis
   Google Scholar
• Yamamoto H, Nagata M, Tabe K, et al. The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993; 91: 79–87
   PubMed Web of Science ®Google Scholar
• Zimmerman T S., Fierar J, Rothberger H. Blood coagulation and the inflammatory response. Semin Hematol 1977; 14: 391–408
   PubMed Web of Science ®Google Scholar
• Kinlough-Rathbone R L., Packham M A., Mustard J F. Vessel injury, platelet adherence and platelet survival. Arteriosclerosis 1983; 3: 524–546
   Google Scholar
• Shattil S, Cunningham M, Hoxie J A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307–315
   PubMed Web of Science ®Google Scholar
• Abrams C., Shattil S J. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467–473
   PubMed Web of Science ®Google Scholar
• Stenberg P E., McEver R P., Shuman M A., Jacques Y V., Bainton D F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880–886
   PubMed Web of Science ®Google Scholar
• Berman C L., Yeo E L., Wencel-Drake J D., Furie B C., Ginsberg M H., Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78: 130–137
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis H K., van Oosterhout J. J.G., Rozemuller E, van Iwaarden F, Sixma J J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in circulation. Blood 1987; 70: 838–845
   PubMed Web of Science ®Google Scholar
• Febbraio M, Silverstein R L. Identification and characterization of LAMP-I as an activation-dependent platelet surface glycoprotein. J Biol Chem 1990; 265: 18531–18537
   PubMed Web of Science ®Google Scholar
• Metzelaar M J., Wijngaard P L., Peters P J. CD63 antigen: a novel lysosomal membrane glycoprotein cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266: 3239–3245
   PubMed Web of Science ®Google Scholar
• Larsen E, Celi A, Gilbert G E., et al. PADGEM Protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305–312
   PubMed Web of Science ®Google Scholar
• Hamburger S A., McEver R P. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550–554
   PubMed Web of Science ®Google Scholar
• Metzelaar M J., Clevers H C. Lysosomal membrane glycoproteins in platelets. Thromb Haemost 1992; 68: 378–382
   PubMed Web of Science ®Google Scholar
• Thompson P J. The human platelet aggregation model for assessing anti-asthma drugs and PAF antagonists. Platelet Activating Factor in Endotoxin and Immune Diseases, D. A. Handley, R. N. Saunders, W. J. Houlihan, J. C. Tomesch. Marcel Dekker Inc, New York 1990; 245–256, Misso NLA
   Google Scholar
• Taylor M L., Misso NLA, Stewart G A., Thompson P J. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. Br J Clin Pharmacol 1992; 33: 25–31
   PubMed Web of Science ®Google Scholar
• Taylor M L., Stewart G A., Thompson P J. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Br J Clin Pharmacol 1993; 35: 227–234
   PubMed Web of Science ®Google Scholar
• Hsu-Lin S C., Berman C L., Furie B C., August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. J Biol Chem 1984; 259: 9121–9126, Studies using a monoclonal antibody specific for thrombin-activated platelets
   PubMed Web of Science ®Google Scholar
• Johnston G I., Pickett E B., McEver R P., George J N. Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 1987; 69: 1401–1403
   PubMed Web of Science ®Google Scholar
• Savage B, Hunter C S., Harker L A., Woods V L., Hanson S R. Thrombin-induced increase in surface expression of epitopes on platelet membrane glycoprotein IIb-IIIa complex and GMP-140 is a function of platelet age. Blood 1989; 74: 1007–1014
   PubMed Web of Science ®Google Scholar
• Parmentier S, McGregor L, Catimel B, Leung L, McGregor J L. Inhibition of platelet functions by a monoclonal antibody directed against a granule membrane glycoprotein GMP140/PADGEM. Blood 1991; 77: 1734–1739
   PubMed Web of Science ®Google Scholar
• de Bruijne-Admiraal L G., Modderman P W., Von Dem Borne A E., Sonnenberg A. P-Selectin mediates Ca2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992; 80: 134–142
   PubMed Web of Science ®Google Scholar
• Israels S J., Gerrard Y V., Jacques A, McNicol B, Chain B, Nishibori M, Bainton D F. Platelet dense granule membranes contain both granulophysin and P-Selectin (GMP140). Blood 1992; 80: 143–152
   PubMed Web of Science ®Google Scholar
• Rosa C A., Rohrer M J., Benoit S E., Rodino L J., Barnard M R., Michelson A D. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg 1994; 19: 306–319, La
   PubMed Web of Science ®Google Scholar
• Shattil S J., Brass L F. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 992–1000
   PubMed Web of Science ®Google Scholar
• Holmsen H. Signal transducing mechanisms in platelets. 1991; 15: 147–152, Proceedings of the National Science Council
   Google Scholar
• McEver R P., Martin M N. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799–9804
   PubMed Web of Science ®Google Scholar
• Metzelaar M J., Sixma J J., Nieuwenhuis H K. Detection of platelet activation using activation specific monoclonal antibodies. Blood Cells 1990; 16: 85–96
   PubMedGoogle Scholar
• Berke O, Farer A. Blood platelet heterogeneity: evidence for two classes of platelets in man and rat. Br J Haematol 1993; 86: 686–691
   Google Scholar
• Hyperreactive platelets and complications of coronary artery disease. N Engl J Med 1987; 316: 1543–1544, HirschJ
   PubMed Web of Science ®Google Scholar